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Exposure to DNA-damaging agents triggers signal transduction pathways that are thought to
play a role in maintenance of genomic stability. A key protein in the cellular processes of
nucleotide excision repair, DNA recombination, and DNA double-strand break repair is the
single-stranded DNA binding protein, RPA. We showed previously that the p34 subunit of RPA
becomes hyperphosphorylated as a delayed response (4–8 h) to UV radiation (10–30 J/m2). Here
we show that UV-induced RPA-p34 hyperphosphorylation depends on expression of ATM, the
product of the gene mutated in the human genetic disorder ataxia telangiectasia (A-T). UV-
induced RPA-p34 hyperphosphorylation was not observed in A-T cells, but this response was
restored by ATM expression. Furthermore, purified ATM kinase phosphorylates the p34 subunit
of RPA complex in vitro at many of the same sites that are phosphorylated in vivo after UV
radiation. Induction of this DNA damage response was also dependent on DNA replication;
inhibition of DNA replication by aphidicolin prevented induction of RPA-p34 hyperphosphory-
lation by UV radiation. We postulate that this pathway is triggered by the accumulation of
aberrant DNA replication intermediates, resulting from DNA replication fork blockage by UV
photoproducts. Further, we suggest that RPA-p34 is hyperphosphorylated as a participant in the
recombinational postreplication repair of these replication products. Successful resolution of these
replication intermediates reduces the accumulation of chromosomal aberrations that would
otherwise occur as a consequence of UV radiation.
INTRODUCTION
Unrepaired DNA damage can lead to mutagenesis and car-
cinogenesis. Exposure to DNA-damaging agents triggers
signal transduction pathways that are thought to play a role
in activating repair and recovery processes (Fornace, 1992;
Lane, 1992; Fuks et al., 1993; Herrlich and Rahmsdorf, 1994).
In mammalian cells, the activation of some of these path-
ways appears to be initiated at the cell membrane, whereas
others appear to be triggered by the DNA damage itself
(Karin and Herrlich, 1989; Karin and Hunter, 1995; Smith et
al., 1999b). Responses to ionizing radiation (IR) appear to be
initiated by the DNA damage itself, leading to activation of
serine/threonine kinases (e.g., DNA-PK and ATM) and re-
sulting in the phosphorylation of key regulatory proteins
such as p53 and CHK1 (Sanchez et al., 1997; Smith et al.,
1999b). ATM-dependent phosphorylation events have been
shown to be required for normal DNA damage-induced
checkpoint control (Lavin and Khanna, 1999). The DNA-
binding protein replication protein A (RPA), which plays an
essential role in DNA replication, recombination, and repair
(Wold, 1997; Iftode et al., 1999) is also a substrate for these
kinases (Zernik-Kobak et al., 1997; Gately et al., 1998; Chan et
al., 2000). RPA becomes phosphorylated as a delayed re-
sponse to UV radiation (Carty et al., 1994). However, the
signal transduction pathway involved is thought to differ
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from that induced by IR because IR-induced phosphoryla-
tion of RPA was shown to be ATM dependent, whereas
UV-induced phosphorylation of RPA appeared to occur nor-
mally in ataxia telangiectasia (A-T) cells (defective in ATM;
Liu and Weaver, 1993). Because of the importance of RPA in
processes required for maintaining genomic stability, such
as DNA repair and recombination, we were interested in
understanding more about the pathway that results in UV-
induced RPA phosphorylation.
RPA is a heterotrimeric, single-stranded DNA-binding
protein (subunits p70, p34, and p14) that functions in DNA
replication, nucleotide excision repair, DNA recombination,
double-strand break (DSB) repair, and transcriptional regu-
lation (Wold, 1997; Iftode et al., 1999). Presumably, RPA
participates in these diverse functions through its strong
affinity for ssDNA and its ability to interact with numerous
DNA replication proteins, including DNA polymerase a and
proliferating cell nuclear antigen (PCNA); nucleotide exci-
sion repair proteins XPA, XPF, and XPG; DNA recombina-
tion and DSB repair proteins Rad51, Rad52, and DNA-PK;
and transcription factors such as p53 (Dutta et al., 1993; He et
al., 1995; Matsuda et al., 1995; Braun et al., 1997; Loor et al.,
1997; Miller et al., 1997; Golub et al., 1998; New et al., 1998;
Stigger et al., 1998; Shao et al., 1999). The p34 subunit of RPA
becomes phosphorylated during the normal cell cycle (Din et
al., 1990). Cell cycle-dependent phosphorylation of RPA-p34
begins at the onset of S phase and continues into mitosis,
and dephosphorylation occurs in the latter part of mitosis,
suggesting a physiological role for RPA-34 phosphorylation
in cell cycle regulation (Din et al., 1990; Fotedar and Roberts,
1992). These cell cycle-dependent phosphorylation events
occur primarily at Ser-23 and Ser-29 (Dutta and Stillman,
1992), which are consensus sites for Cdc2 cyclin-dependent
kinase (Pan et al., 1994; Niu et al., 1997). These phosphory-
lated forms of RPA-p34 can be observed on immunoblots of
polyacrylamide gels as more slowly migrating forms (Din et
al., 1990; Carty et al., 1994).
RPA-p34 is hyperphosphorylated in response to DNA
damage, converting a significant amount of the protein to its
slowest migrating form (Carty et al., 1994; Zernik-Kobak et
al., 1997; Shao et al., 1999). The kinetics of RPA-p34 hyper-
phosphorylation differ depending on the DNA-damaging
agent. With low dose IR (2–10 Gy), hyperphosphorylation
first appears at ;1–2 h and peaks at 3–4 h after treatment
(Liu and Weaver, 1993; Cheng et al., 1996); in contrast, with
low dose UVC radiation (10–30 J/m2 UV) the hyperphos-
phorylated form does not begin to appear until 2–4 h after
treatment and reaches a maximum at around 8–10 h (Carty
et al., 1994). These results suggest that either the inducing
signal or the signal transduction pathway leading to RPA-
p34 hyperphosphorylation differs, depending on the geno-
toxic agent. We have shown that UV-induced hyperphos-
phorylation results in the phosphorylation of at least six
serines and one threonine within the N-terminus of RPA-
p34 (Zernik-Kobak et al., 1997). All of these sites within
RPA-p34 can be phosphorylated in vitro when the RPA
complex (p70, p34, and p14) is incubated with purified
DNA-PK and double-stranded DNA (Zernik-Kobak et al.,
1997). However, it is not clear what cellular enzymes are
responsible for UV-induced hyperphosphorylation of RPA
in vivo.
To investigate the role of the ATM kinase, we examined
the capacity of A-T cells to carry out UV-induced RPA-p34
hyperphosphorylation. Here we demonstrate that A-T cells
are defective in UV-induced hyperphosphorylation of RPA.
When normal cells were irradiated with 10 J/m2 UVC, max-
imal RPA hyperphosphorylation was observed at 8–12 h
after exposure. In A-T cells, we did not observe the most
highly phosphorylated form of RPA for 24 h after UV expo-
sure. In addition, we used recently developed inducible cell
lines (Zhang et al., 1997, 1998) to show that expression of
recombinant ATM protein in A-T cells corrected defective
UV-induced hyperphosphorylation of RPA-p34. Further-
more, normal cells expressing antisense ATM cDNA became
defective in UV-induced hyperphosphorylation of RPA-p34.
A direct role for ATM in RPA-p34 hyperphosphorylation in
vivo was suggested by the demonstration that purified ATM
phosphorylated RPA-p34 in the purified three-subunit RPA
complex in vitro on many of the same sites as are phosphor-
ylated in vivo after UV radiation.
The time delay in UV radiation-induced RPA-p34 hyper-
phosphorylation suggests that this pathway is not induced
directly by UV-induced photoproducts. Furthermore, be-
cause hyperphosphorylation occurs normally in nucleotide
excision repair (NER)- deficient xeroderma pigmentosum
group A (XPA) cells, the inducing signal does not appear to
be an NER intermediate. Studies with synchronized cells
suggest instead that replication of UV-damaged templates is
required for generation of the inducing signal. On the basis
of these observations, we postulate that the regions of single-
stranded DNA and/or DNA strand breaks that are known
to occur at replication forks blocked by UV-induced DNA
template damage serve as the inducing signal(s) for ATM
activation and RPA hyperphosphorylation.
MATERIALS AND METHODS
Cell Culture
The human skin-derived SV40-transformed fibroblast GM00637G
(normal), AT5BIVA (A-T homozygous), and GM04429 (XP12BE;
XPA) cell lines were obtained from the National Institute of General
Medical Sciences Human Genetic Mutant Cell Repository (Coriell
Institute for Medical Research, Camden, NJ). The SV40-transformed
LM217 (normal) and AT3BISV (A-T homozygous) cell lines were
generous gifts of Dr. Leon Kapp at the University of California at
San Francisco. MO59K and MO59J (DNA-PKcs deficient) glioblas-
toma cells were generous gifts of Dr. Joan Allalunis-Turner (Cross
Cancer Institute, Edmonton, Alberta, Canada). Recently, the two
“normal” cell lines (LM217 and GM00637) were shown to be het-
erozygous for mutations in ATM (Wright et al., 1996). We have
detected ATM protein by Western immunoblotting in these two
normal lines but not in the two A-T lines used here (our unpub-
lished results). AT1ABR is an Epstein Barr virus (EBV)-transformed
A-T lymphoblastoid human cell line that contains a homozygous
in-frame 9-bp deletion (codons 2546–2548) located upstream of the
PI-3 kinase domain (codons 2855–2875), which causes a lack of
kinase activity (Savitsky et al., 1995). These cells have been trans-
fected with the ATM cDNA expression vector, pMAT1 with a
metallothionein II promoter (Zhang et al., 1997), allowing CdCl2-
inducible expression of ATM. C3ABR is an EBV-transformed nor-
mal lymphoblastoid cell line. These cells were transfected with a
CdCl2-inducible antisense ATM cDNA expression vector, pMAT2
(Zhang et al., 1998).
Cell cultures were maintained at 37°C in a humidified atmo-
sphere containing 5% CO2. Normal and A-T fibroblast cells were
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grown in minimal essential medium (MEM) supplemented with
antibiotics, 15–20% fetal bovine serum (FBS), 2% essential amino
acids, 1% nonessential amino acids, and 1% vitamins. MEM and all
supplements were obtained from Life Technologies (Gaithersburg,
MD). Human HeLa and XP12BE cells were grown in Dulbecco’s
minimal essential medium (DMEM), containing 10% FBS and anti-
biotics, and MO59J and MO59K cells were grown in DMEM/F12
supplemented with 10% FBS and antibiotics at 37°C and 5% CO2.
Lymphoblasts were maintained in RPMI 1640 medium with 10%
FBS and hygromycin B (0.2 mg/ml). Cells were maintained by
subculturing at a ratio of 1:3, every 3 to 4 days, for at least 2 passages
(;24 h doubling time) before plating for experimentation. Cells
were not maintained in culture longer than 15–20 passages. Induc-
tion of the ATM cDNA expression vector in pMAT1-transfected
AT1ABR cells and the antisense ATM expression vector in pMAT2-
transfected C3ABR cells was achieved by treatment with 5 mM
CdCl2 for 8 h. After either CdCl2 induction or mock induction, the
cells were washed twice with Hanks’ buffered saline solution
(HBBS), and the growth medium was replaced with fresh medium.
After 8 h of CdCl2 induction the cells were treated with UVC
radiation as described below.
Radiation Exposure
UVC radiation was delivered using a low-pressure mercury lamp
(Mineralight lamp, model UVG-11; UVP, Inc., San Gabriel, CA) with
maximal output at 254 nm. Before UV radiation exposure, medium
was removed from the cells, and cells were washed twice in HBSS
or phosphate-buffered saline (PBS; 58 mM Na2HPO4, 17 mM
NaHPO4, 68 mM NaCl, 3 mM KCl). Cells were irradiated in buffer,
which was then removed, and the growth medium previously
removed from the cells (held at 37o during irradiation) was re-
turned. The cell lines AT5BIVA, GM00637, LM217, MO59J, and
MO59K all had similar clonigenic survival after UVC radiation; the
XP12BE line had the expected increased sensitivity to UVC-induced
cell killing.
Cell Synchronization
To obtain cells primarily in S phase, asynchronous cells were treated
with 6 mM aphidicolin (Sigma-Aldrich, St. Louis, MO) for 16–20 h.
The medium containing aphidicolin was removed, and cells were
washed twice in serum-free medium and then incubated in serum-
containing medium for an additional 2–4 h. The efficacy of the
aphidicolin block and release protocol in LM217 and AT5BIVA cells
was measured by labeling cells with bromodeoxyuridine (BrdU).
Cells were fixed onto microscope slides, and BrdU uptake was
detected with FITC-labeled anti-BrdU antibody and compared with
propidium iodide (PI) staining by fluorescence microscopy. PI-
stained nuclei were counted, and those that also stained positive for
FITC were counted as positive for DNA synthesis. After 20 h of
incubation with aphidicolin, ,5% of both LM217 and AT5BIVA
cells were labeled with anti-BrdU; 4 h after release from the aphidi-
colin block, the percentage of cells labeled with anti-BrdU in both
cell lines had increased to 55–60%. To obtain cells synchronized in
G1/S phase, HeLa cells were treated with 0.3 mM nocodazole for
16 h. Mitotic cells were collected by shaking the cells off the dish and
pelleting them. Mitotic cells were released from nocodazole treat-
ment for 7.5 h in fresh medium. The efficacy of the nocodazole block
and release protocol was measured by double labeling cells with 3H-
and 14C-thymidine as described below.
DNA Synthesis Assay
Thymidine incorporation was assayed essentially as described pre-
viously (Shao et al., 1997). Briefly, cells were prelabeled with 0.01
mCi/ml 14C-thymidine (NEN Life Science Products, Inc., Boston,
MA) for 24 h at 37°C. After incubation in fresh medium for 1 h, cells
were treated with aphidicolin as above. The rate of DNA synthesis
after release from aphidicolin treatment was measured by 3H-thy-
midine incorporation during a 30 min pulse with 10 mCi/ml 3H-
thymidine (NEN Life Science Products, Inc., Boston, MA). After
labeling with 14C- and 3H-thymidine, cells were washed with PBS
twice and lysed with 500 ml of 0.2 M NaOH. Triplicate samples (150
ml each) were collected onto squares of Whatman No. 3 filters
(Whatman International, Maidstone, England) and rinsed with 5%
trichloroacetic acid and 100% ethanol. The radioactivity of each
sample was counted by dual-label liquid scintillation, and the ratio
of 3H/14C reflected the DNA synthesis activity.
Immunoblotting
For Western immunoblots, cells were lysed in 2 ml PBSTDS (58 mM
Na2HPO4, 17 mM NaHPO4, 68 mM NaCl, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% SDS) that included 1 mg/ml leupeptin,
1 mg/ml pepstatin, 1 mg/ml aprotinin, 0.1 mM PMSF, 5 mM NaF,
and 1 mM Na vanadate. The insoluble fraction was pelleted by
centrifugation at 3600 3 g for 15 min at 4°C, and the supernatant
was removed and stored at 270°C until use. Total protein concen-
tration of cell lysates was determined by using the Coomassie Plus
Protein assay (Pierce, Rockford, IL). Samples (50 mg total protein for
RPA detection and 100 mg total protein for ATM and DNA-PK
detection) were solubilized in Laemmli sample loading buffer,
boiled at 100°C for 5 min, and then separated on 12% (for RPA) or
6% (for ATM and DNA-PK) denaturing SDS polyacrylamide gels
(monomer to cross-linker ratio, 37:5:1) using the Laemmli buffer
system (Laemmli, 1970). Proteins were transferred to Immobilon-P
polyvinyl-divinyl fluoride (PVDF) transfer membranes (Millipore
Corp., Bedford, MA) using a semidry apparatus (Bio-Rad Labora-
tories, Hercules, CA) at a maximum of 150 mA and 20 V for 1.5–2 h.
The nontransferred portion of the gel was stained with 0.15% Coo-
massie blue to ensure equal loading of the protein samples. The
membranes were blocked for 0.5–1 h with TTBS (100 mM Tris-HCl
[pH 7.5], 0.9% NaCl, 0.3% Tween-20) containing 5% powdered
milk and then probed with anti-ATM (1:2500; Novus Biologicals,
Littleton, CO or Ab-3, Oncogene Science), anti-DNA-PK (1 mg/ml
Ab-1; Oncogene Science, Cambridge, MA), anti-ATR (2 mg/ml Ab-1;
Oncogene Science), or anti-RPA-p34 (2 mg/ml Ab-3, Oncogene Sci-
ence; or a 1:1500 dilution of monoclonal antibody 34A [Kenny et al.,
1990]) for 1–2 h. After washing four times with TTBS, the mem-
branes were incubated with horseradish peroxidase–linked second-
ary antibody; sheep anti-mouse secondary antibody was used for
RPA (1:2000), and donkey anti-rabbit secondary antibody was used
for ATM and DNA-PK (1:1500 and 1:3000, respectively; Amersham
Life Science Inc., Arlington Heights, IL). Membranes were washed
three times in TTBS, and the proteins were visualized using the ECL
chemoluminescent method (Amersham Life Science Inc.).
Nuclear Extract Preparation
Nuclear extracts were prepared as previously described (Andrews
and Faller, 1991) with slight modifications, using hypotonic lysis
followed by high salt extraction of nuclei. Briefly, frozen cell pellets
were resuspended in 400-1000 ml of buffer A (10 mM HEPES-KOH
[pH 7.9] at 4°C, 1.5 mM MgCl2, 10 mM KCl, 1 mM dithiothreitol
[DTT], 0.5 mM PMSF, 20 mM b-glycerophosphate, 10 mM p-nitro-
phenylphosphate, 0.1 mg/ml pepstatin, and aprotinin). Cells were
allowed to swell for 10 min, vortexed for 10 s, and centrifuged for
10 s at 23,000 3 g. The pellet was resuspended in twice its volume
of buffer C (10 mM HEPES-KOH [pH 7.9] at 4°C, 5% glycerol, 420
mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF,
20 mM b-glycerophosphate, 10 mM p-nitrophenylphosphate) and
incubated on ice for 20 min. The nuclear protein fraction was
isolated by centrifugation for 10 min at 23,000 3 g and collected as
the supernatant fraction. Total protein concentration of nuclear
extracts was determined by using the Coomassie Plus Protein assay
(Pierce)
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Purification of RPA
The RPA protein was expressed and purified from Escherichia coli
BL21 (DE3) cells transformed with p11d-tRPA vector (a gift from Dr.
Marc Wold, University of Iowa, Iowa City, IA) as described previ-
ously (Henricksen et al., 1994). The p11d-tRPA vector coexpresses all
three RPA subunits (RPA-p70, RPA-p34, and RPA-p14).
Purification of ATM
ATM was purified according to recently published methods (Smith
et al., 1999a) with minor modifications. Briefly, HeLa nuclear ex-
tracts were prepared according to Dignam et al. (1983) from 20 liter
of HeLa S3 cells (Cell Culture Center, Minneapolis, MN) and equil-
ibrated in buffer D (22 mM HEPES/KOH [pH 7.6], 20% glycerol, 2
mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 0.5 mM PMSF, and 1 mM
Na metabisulfite) containing 50 mM KCl. Nuclear extract (16 ml)
was loaded onto a Q-Sepharose column (20 ml, 1.6 3 10 cm; Am-
ersham Pharmacia Biotech, Piscataway, NJ) that was equilibrated in
50 mM KCl buffer D and washed with 2.5 column volumes (50 ml)
of buffer D containing 100 mM KCl. The column was eluted with a
100-ml continuous salt gradient of 50–500 mM KCl in buffer D, and
2-ml fractions were collected. The Q-Sepharose column fractions
containing ATM as detected by immunoblotting were dialyzed
against 2 liters of 50 mM KCl buffer D overnight. The dialysate was
fractionated by size exclusion chromatography on a gel filtration
column (1.6 3 100 cm with Sephacryl SR-400 HR, 10,000–2000,000;
Sigma-Aldrich) equilibrated with buffer A (50 mM Tris-HCl [pH
7.5], and 100 mM KCl), collecting 1-ml fractions. Fractions contain-
ing ATM eluting in the 350- to 450-kDa range were identified by
immunoblotting, pooled (16 ml total), and dialyzed overnight
against 50 mM KCl buffer D. The pooled fractions were loaded onto
a heparin agarose column (5 ml, 1.6 3 2.5 cm; Amersham Pharmacia
Biotech) equilibrated with 50 mM KCl buffer D and washed after
sample application with eight column volumes of buffer D contain-
ing 100 mM KCl. The column was eluted with a 50 ml KCl contin-
uous gradient from 50 to 500 KCl, and 1-ml fractions eluting at
230–240 mM KCl were identified, pooled, and dialyzed against 2
liters of 50 mM KCl buffer D. The pooled ATM fractions were
incubated with 150 mg of biotinylated 50-bp dsDNA conjugated to
streptavidin-coated iron oxide beads (Dynal, Lake Success, NY) on
a rotator at 4°C for 1 h. The ATM-DNA complexes were collected
using a magnetic stand (Dynal) and washed five times with 0.5 ml
of 50 mM KCl buffer D. ATM protein was eluted with 250 mM KCl
buffer D (200 ml).
Protein Kinase Assays
Kinase reactions were performed by incubating purified ATM or 10
U of DNA-PKcs/Ku (Promega, Madison, WI) or 20 U of Cdc2p34/
Cyclin B (New England Biolabs, Beverly, MA) at 37°C for 30 min. in
30 ml of kinase buffer (20 mM HEPES [pH 7.4], 10 mM MgCl2, 100
mM ATP, 2 mM DTT, 0.2 mg of single-stranded fX174 virion DNA
(ssDNA), 10 mCi [g-32P]ATP, and 0.5 mg of purified RPA). The
kinase reaction was stopped by the addition of 13 Laemmli sample
loading buffer. Proteins were separated on 12% denaturing SDS-
PAGE gels and exposed to film.
Two-dimensional Phosphopeptide Mapping
Purified recombinant RPA complex was phosphorylated by either
purified ATM or 10 U of DNA-PK for 30 min. Hyperphosphorylated
RPA-p34 was separated by SDS-PAGE and transferred to a PVDF
membrane. The hyperphosphorylated form was detected by phos-
phorimager analysis and excised from the membrane. The PVDF
membrane pieces containing phosphorylated RPA-p34 were
blocked with polyvinylpyrrolidone 360 (0.5% in 100 mM acetic acid)
and then subjected to chymotrypsin/trypsin digestion (2 3 10 mg of
chymotrypsin for 2 h at 37°C; Boehringer Mannheim, Indianapolis,
IN; Luo et al., 1990). After digestion, the peptides were oxidized
with performic acid for 1 h at 25°C. Phosphorylated RPA-p34 chy-
motryptic/tryptic peptides were separated on TLC plates by elec-
trophoresis in pH 1.9 buffer in the first dimension (anode on the left,
cathode on the right) by using a model HRH gel electrophoresis
apparatus (International Biotechnologies, Inc., New Haven, CT) and
ascending chromatography in isobutyric acid buffer (62.5% isobu-
tyric acid, 4.8% pyridine, 2.9% glacial acetic acid, 1.9% n-butanol) in
the second dimension (Luo et al., 1990). The phosphorylated pep-
tides were visualized by phosphorimager analysis (Storm model 860
phosphorimager; Molecular Dynamics, Sunnyvale, CA).
RESULTS
RPA-p34 Hyperphosphorylation in Asynchronous
Cell Cultures
We showed previously that hyperphosphorylation of the
p34 subunit of RPA occurs 4–8 h after exposure of HeLa
cells to UVC radiation (10–30 J/m2; Carty et al., 1994). Be-
cause phosphorylated forms of RPA-p34 migrate slower on
SDS-PAGE than do unphosphorylated forms (Carty et al.,
1994; Brush et al., 1996), changes in phosphorylation can be
measured by Western immunoblotting of cell lysates. To
determine whether UV-induced hyperphosphorylation of
RPA-p34 occurs normally in A-T cells, we compared the gel
migration pattern of RPA-p34 from SV40-transformed skin
fibroblast cell lines from normal individuals (LM217 and
GM00637) and A-T patients (AT5BIVA and AT3BISV). Rap-
idly growing subconfluent monolayer cultures were either
irradiated with 10 J/m2 UVC or mock-irradiated. At various
times after irradiation, whole cell lysates or nuclear extracts
were prepared, and proteins were separated on SDS-PAGE,
blotted to membranes, and probed with antibody against
RPA-p34. In Figure 1A, mock-irradiated LM217 cells show
three major cell cycle–dependent forms of RPA-p34 (bands
1–3), and the pattern of forms did not change during a 32-h
time course. Lysates prepared from LM217 cells 4 h after UV
exposure (10 J/m2) contained at least two additional slower
migrating forms of RPA-p34 (bands 4 and 5). The intensity
of the slowest migrating form (band 5, the hyperphospho-
rylated form) increased to a maximum at 12 h postexposure.
Hyperphosphorylation of RPA-p34 was also seen in a time-
(our unpublished results) and dose-dependent manner in
another normal cell line, GM00637, that was exposed to 10
J/m2 UVC (Figure 1C, lanes 1 and 2). The general pattern of
UV-induced phosphorylation of RPA-p34 that we observed
was comparable among HeLa (Carty et al., 1994), LM217,
and GM00637 cells.
Figure 1B shows that the three faster-migrating forms of
RPA-p34 seen in LM217 cells are also observed in mock-
irradiated A-T cells, although form 3 appears to be less
intense than in the normal cells. However, after exposure of
A-T cells to 10 J/m2 UVC, there was very little change in the
banding pattern of RPA-p34. Only a very faint band was
observed at the position of the hyperphosphorylated form
(band 5). A similar result (Figure 1C) was obtained from the
analysis of UVC-induced RPA-p34 hyperphosphorylation in
nuclear extracts from another normal cell line (GM00637;
lanes 1 and 2) and another A-T cell line (AT3BISV; lanes 5
and 6). These data suggest that UV-induced hyperphospho-
rylation of RPA depends on expression of ATM.
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UV-induced RPA Phosphorylation in Cells
Expressing Inducible Recombinant ATM Protein or
ATM cDNA Antisense Transcript
In order to confirm that the difference in UV-induced hyper-
phosphorylation of RPA-p34 observed in A-T cells versus
normal cells is due to the presence or absence of ATM, we
used A-T cells expressing recombinant ATM protein or nor-
mal cells expressing ATM antisense cDNA both under con-
trol of the metallothionein promoter and inducible with
CdCl2. We used the A-T lymphoblastoid cell line AT1ABR,
and the normal cell line C3ABR transfected with either an
inducible full-length ATM cDNA or an antisense ATM
cDNA, respectively (Zhang et al., 1997, 1998). We confirmed
by Western immunoblotting that expression of ATM was
induced in the A-T cells and repressed in the normal cells by
incubation in the presence of CdCl2. The AT1ABR cell line
contains a homozygous 9-bp in-frame deletion starting at
codon 2546 of the open reading frame (Zhang et al., 1997).
This enables AT1ABR cells to produce a near full-length but
nonfunctional protein and is consistent with our detection
by immunoblotting of endogenous ATM protein in unin-
duced AT1ABR cells (Figure 2A, top left lane 1). As shown
in Figure 2A, top left lane 2, the amount of ATM protein
increased in AT1ABR cells after CdCl2 treatment. The induc-
tion of antisense ATM cDNA by CdCl2 in transfected
C3ABR cells reduced the level of ATM protein detected at
8 h postinduction (Figure 2A, top right lane 4). The expres-
sion of DNA-PK remained constant after CdCl2 treatment in
both A-T cells and normal cells (Figure 2A, bottom panels).
First, we examined whether expression of ATM in A-T
cells could affect UV-induced hyperphosphorylation of
Figure 1. RPA-p34 phosphorylation in asynchronous normal and
A-T cells exposed to 10 J/m2 UVC. Cell lysates (A and B) or nuclear
extracts (C) were prepared from asynchronously growing cells at
indicated times after 10 J/m2 UV radiation or mock exposure. The
p34 subunit of RPA was detected by Western immunoblotting with
monoclonal antibody 34A. Phosphorylation causes a slower migra-
tion on the gel; at least five different forms of the p34 subunit of RPA
can be visualized. (A) RPA-p34 in LM217 cells; (B) RPA-p34 in
AT5BIVA cells; (C) RPA-p34 in nuclear lysates of GM00637 (lanes 1
and 2), AT5BIVA (lanes 3 and 4), and AT3BISV (lanes 5 and 6) cells.
Band 1 is unphosphorylated RPA-p34; bands 2 and 3 are cell cycle–
dependent phosphorylated forms; and band 5 is the DNA damage–
induced hyperphosphorylated form. Figure 2. (A) Expression of ATM and DNA-PK proteins in pMAT1
stably transfected A-T cells (AT1ABR) and pMAT2 stably transfected
normal C3ABR cells. Cells were treated with 5 mM CdCl2 for 8 h. Whole-
cell lysates (100 mg) were analyzed by SDS-PAGE and immunoblotted
with anti-ATM (Ab-3; Oncogene Science) antibodies (top panels).
AT1ABR is the parental A-T cell line containing a homozygous 9-bp
in-frame deletion and is capable of producing near full-length but non-
functional protein. Upon induction of the transfected line, a functional
full-length recombinant ATM protein is produced. C3ABR is a control
lymphoblastoid cell line expressing normal ATM. Induction of the trans-
fected line reduces ATM expression. Membranes were reblotted with
anti-DNA-PKcs antibody (Ab-1; Oncogene Science; bottom panels). (B)
Phosphorylation of RPA-p34 after exposure of cells to UVC radiation.
AT1ABR cells, transfected with a CdCl2-inducible ATM cDNA expression
vector pMAT1, and C3ABR cells, transfected with an inducible antisense
ATM cDNA expression vector pMAT2, were treated with 5 mM CdCl2 for
8 h (1) or mock-treated (2). After 8 h of CdCl2 treatment, cells were UVC
irradiated (30 J/m2) or mock-irradiated. Eight hours after UV treatment,
whole-cell lysates were prepared and RPA-p34 was examined by gel
electrophoresis, followed by immunoblotting with anti-RPA-p34 (Ab-3;
Oncogene Science) antibody. (C) DNA-PKcs (left) and ATM (right) expres-
sion in MO59J and MO59K cells detected in whole-cell lysates by immu-
noblotting. (D) MO59J and MO59K cells were irradiated with 30 J/m2 UV,
and whole-cell lysates were prepared at the indicated times after UV
irradiation. RPA-p34 hyperphosphorylation was detected by immunoblot-
ting using anti-RPA-p34 (Ab-3; Oncogene Science) antibody. To ensure
equal loading and transfer of the protein samples, the gels and the PVDF
membranes were stained with Coomassie blue and colloidal gold solu-
tion, respectively.
UV- and ATM-dependent RPA Phosphorylation
Vol. 12, May 2001 1203
RPA-p34. Cells were grown in the presence or absence of
CdCl2, whole cell lysates were prepared 8 h after UVC (30
J/m2) treatment, and lysate proteins were subjected to West-
ern blot analysis using anti-RPA-p34 antibody. After UV
irradiation, a weak band was detectable at the position of the
hyperphosphorylated form of RPA-p34 in AT1ABR cells in
the absence of expression of recombinant ATM protein (Fig-
ure 2B, lane 2). However, after induction of expression of
full-length recombinant ATM protein in AT1ABR cells, the
UV-induced hyperphosphorylation of RPA increased sub-
stantially (Figure 2B, lane 4), indicating that the expression
of full-length ATM protein increased RPA-p34 phosphory-
lation. As expected, the mock-irradiated AT1ABR cells did
not exhibit a hyperphosphorylated form regardless of CdCl2
induction, although cell cycle–dependent forms of phos-
phorylated RPA-p34, having intermediate gel mobility,
could be detected in these cells (Figure 2B, lanes 1 and 3).
We next investigated whether decreased expression of
ATM protein in normal cells could affect RPA-p34 hyper-
phosphorylation. Cell lysates prepared from UV-irradiated
(30 J/m2), uninduced C3ABR cells showed hyperphospho-
rylation of RPA, as demonstrated by the presence of the
slow-migrating form of RPA-p34 (Figure 2B, lane 6). This
band was not observed in mock-irradiated C3ABR cells
(Figure 2B, lane 5). After induction of expression of ATM
cDNA antisense transcripts in the transfected C3ABR cells,
hyperphosphorylation of RPA-p34 was not detected at 8 h
after UV irradiation (Figure 2B, lane 8) or after mock irradi-
ation (Figure 2B, lane 7). These data demonstrate that UV-
induced hyperphosphorylation of RPA-p34 is dependent on
ATM expression.
RPA-p34 Hyperphosphorylation in a DNA-PKcs–
deficient Cell Line
We showed previously that purified DNA-PK can hyper-
phosphorylate RPA-p34 in vitro (Zernik-Kobak et al., 1997).
To determine whether DNA-PK also participates in UV-
induced RPA-p34 hyperphosphorylation in vivo, we com-
pared RPA-p34 phosphorylation in DNA-PKcs–deficient
MO59J glioblastoma cells and DNA-PKcs–expressing
MO59K cells derived from the same tumor specimen (Lees-
Miller et al., 1995). Western blot analysis of cell lysates from
DNA-PKcs–deficient MO59J cells confirmed that these cells
lack detectable DNA-PKcs (Figure 2C). However, these cells
showed only low levels of ATM protein expression as well
(Figure 2C), consistent with previous reports (Chan et al.,
1998; Gately et al., 1998). In MO59K cells, we observed
normal levels of both DNA-PKcs and ATM (Figure 2C). As
shown in Figure 2D, RPA-p34 hyperphosphorylation after
UV irradiation was observed in both MO59J and MO59K
cells. The hyperphosphorylated band appears to be slightly
less intense in the MO59J cells, suggesting that either
DNA-PK participates in UV-induced hyperphosphorylation
of RPA-p34 or that the reduced levels of ATM in these cells
causes a reduction in RPA-p34 hyperphosphorylation. The
fact that RPA-p34 hyperphosphorylation occurs at all in
DNA-PKcs–deficient cells (Fried et al., 1996) suggests that in
vivo, a kinase in addition to DNA-PK is involved in UV-
induced RPA-p34 hyperphosphorylation.
Hyperphosphorylation of RPA-p34 In Vitro by
Purified ATM
We next asked whether ATM kinase itself might be respon-
sible for phosphorylation of RPA-p34. To address this ques-
tion, we tested the capacity of purified ATM to phosphory-
late the p34 subunit of purified RPA complex in vitro. We
purified ATM from HeLa nuclei according to recently pub-
lished procedures (Smith et al., 1999a). We confirmed sepa-
ration of ATM from DNA-PK at the heparin agarose chro-
matography step of the purification by Western
immunoblotting of fractions from the column (Figure 3,A
and B). Fractions eluting at 230–250 mM KCl (e.g., fractions
29–33, Figure 3, A–C) were pooled for further purification.
ATM was further separated from ATR in the final DNA-
binding step of the purification. Immunoblotting of the ATM
eluate for the presence of DNA-PK and ATR (ATM- and
RAD3-related protein) demonstrated that these proteins
were absent from the conjugated ATM-DNA purified frac-
tions (Figure 3D).
Purified RPA complex was incubated with purified ATM
and [g-32P]dATP in the presence of single-stranded DNA.
DNA-PK and cyclin B/cdc2 kinase, which are known to
phosphorylate RPA in vitro (Dutta and Stillman, 1992; Brush
et al., 1994; Henricksen et al., 1996) were included as controls.
The results in Figure 3E demonstrate that RPA-p34 becomes
hyperphosphorylated in the presence of ATM. Furthermore,
this kinase activity is sensitive to 50 nM wortmanin (our
unpublished results), ruling out the ATR kinase, which is
only sensitive to much higher concentrations (Sarkaria et al.,
1998). Although ATM is less active than DNA-PK, the shift
in mobility of RPA-p34 is comparable with ATM and DNA-
PK, suggesting that a similar number of sites on RPA-p34
are phosphorylated by the two kinases. In contrast, cyclin
B/cdc2 kinase-mediated phosphorylation resulted primarily
in a single labeled band, consistent with the known speci-
ficity of this kinase for only two sites (serines 23 and 29) on
RPA-p34 (Pan et al., 1994; Niu et al., 1997). These results
demonstrate that ATM has the capacity to phosphorylate the
p34 subunit of RPA complex in vitro, suggesting that ATM
could play a direct role in UV-induced hyperphosphoryla-
tion in vivo. These results are consistent with those of Chan
et al. (2000), who demonstrated that ATM, purified from
human placenta, had the capacity to phosphorylate RPA-
p34.
Mapping of the Sites of Phosphorylation of RPA-
p34 by ATM Kinase
We showed previously that DNA-PK phosphorylates the
p34 subunit of the RPA complex in vitro at many of the same
sites that are phosphorylated in vivo after UV-irradiation
(Zernik-Kobak et al., 1997). To determine whether ATM has
similar substrate specificity to DNA-PK, we carried out two-
dimensional peptide mapping of the phosphorylated RPA-
p34 protein bands. The hyperphosphorylated form was sep-
arated by SDS-PAGE, transferred to PVDF membrane,
excised, and digested with trypsin/chymotrypsin. The re-
sulting peptides were separated in two dimensions and
visualized by phosphorimager analysis (Figure 4). Overall, a
similar pattern of phosphorylation was observed with ATM
as with DNA-PK. Cochromatography of ATM- and DNA-
PK-phosphorylated RPA-p34 confirmed those similarities
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(Figure 4, right panel). Both kinases exhibited strong phos-
phorylation of peptide 6 on two sites (pp6). As reported
previously (Zernik-Kobak et al., 1997), phosphorylation of
peptide 7 on two sites (pp7) by DNA-PK could also be
detected; however, with ATM it appears to be phosphory-
lated to a lesser extent. Although both DNA-PK and ATM
appeared to phosphorylate peptide 4 (p4), DNA-PK phos-
phorylated other peptides (probably peptides 2 and 3) more
strongly. These results demonstrate that ATM phosphory-
lates RPA-p34 at multiple sites, and many of these sites
appear to be the same as those phosphorylated by DNA-PK.
However, there appear to be additional phosphopeptides
near peptide 6 (pp6) and in the top right quadrant unique to
the ATM map, suggesting some differences in the site spec-
ificities of the two kinases in vitro. The functional signifi-
cance of these phosphorylation events remains to be deter-
mined. However, published reports suggest a role for RPA
phosphorylation in DNA replication and interaction with
other regulatory proteins (Iftode et al., 1999).
The next series of experiments were carried out to under-
stand more about the inducing signal for ATM-dependent,
UV-induced hyperphosphorylation of RPA-p34. The fact
that the time of appearance of the hyperphosphorylated
form of RPA-p34 is delayed (appears at 4–8 h) after UV
radiation compared with IR (appears at 1–3 h) suggests that
UV-induced DNA damage (i.e., primarily pyrimidine cy-
clobutane dimers and 6-4 photoproducts) does not induce
this pathway directly. With IR, the inducing signal is
thought to be DNA strand breaks (Nelson and Kastan, 1994),
although there is no direct evidence supporting this mech-
anism.
RPA p34 Hyperphosphorylation Does Not Require
Nucleotide Excision Repair
We first tested the possibility that the signal for UV-induced
hyperphosphorylation of RPA-p34 was generated as a result
of nucleotide excision repair (NER) of UV photoproducts. To
test whether NER was necessary for induction of RPA-p34
hyperphosphorylation after UV radiation, we used a XPA
cell line, which is deficient in the recognition and excision
steps of NER. UV irradiation of XPA cells led to a strong
induction of hyperphosphorylated RPA-p34 (Figure 5).
These results indicate that the induction of RPA-p34 hyper-
phosphorylation by UV irradiation does not require active
NER.
RPA p34 Hyperphosphorylation Is Associated with
Replication of UV-damaged DNA
Replication of UV-damaged DNA templates leads to repli-
cation fork blockage at sites of damage (Park and Cleaver,
1979; Bierne and Michel, 1994; Seigneur et al., 1997). If block-
age occurs on the leading strand, continued replication on
the lagging strand leads to the accumulation of long
stretches of single-stranded parental DNA (Wang and
Smith, 1986; Kaufmann, 1989; Michel et al., 1997). In addi-
tion, DNA double-strand breaks occur at blocked replication
forks (Wang and Smith, 1986; Kaufmann, 1989; Michel et al.,
1997). If these abnormal DNA structures serve as signals for
induction of RPA-p34 hyperphosphorylation, we would ex-
pect that induction would occur more intensely and more
rapidly if synchronized cells were irradiated at the begin-
ning of S phase. To test this hypothesis, cells were synchro-
nized by nocodazole and then released for 7.5 h to place
them at the G1/S border (Figure 6B). Cells were then irra-
diated with 30 J/m2 UV and incubated further in the pres-
ence or absence of aphidicolin (Figure 6C). In the absence of
aphidicolin, hyperphosphorylation of RPA-p34 was ob-
Figure 3. Purification and kinase activity of ATM. (A) Western
immunoblot of fractions from heparin agarose affinity column. A
100-ml aliquot of the indicated fractions was analyzed on a 6%
SDS-polyacrylamide gel, transferred to PVDF membrane, and
probed with antibody to ATM (Novus Biologicals). (B) The PVDF
membrane was reprobed without stripping with antibody to DNA-
PKcs (Ab-1; Oncogene Science). (C) ATR was detected with anti-
ATR (Ab-1; Oncogene Science) without stripping the membrane. (D)
Western immunoblot of HeLa cell nuclear extract (70 mg), DNA-
PKcs/Ku (100 U; Promega), and purified ATM (35 ml). The samples
were analyzed on a 6% SDS-polyacrylamide gel, transferred to
PVDF membrane, and probed with antibody to ATM (left; Novus
Biologicals). The PVDF membrane was reprobed without stripping
with antibody to DNA-PKcs (center, Ab-1; Oncogene Science), and
ATR was detected with anti-ATR (right, Ab-1; Oncogene Science).
(E) Phosphorylation of RPA by Cdc2p34/cyclin B (New England
Biolabs) purified ATM and DNA-PKcs/Ku (Promega). Purified re-
combinant RPA heterotrimer (0.5 mg) was incubated with either
Cdc2p34/cyclin B (20 U), purified ATM or DNA-PKcs/Ku (10 U) in
a 30-ml reaction containing 20 mM HEPES (pH 7.4), 10 mM MgCl2,
100 mM ATP, 2 mM DTT, 0.2 mg of single-stranded fX174 virion
circular DNA, and 10 mCi [g-32P]ATP. Samples were incubated for
30 min at 37°C. The kinase reaction was stopped by the addition of
13 Laemmli sample loading buffer, and samples were separated on
12% SDS-polyacrylamide gels followed by autoradiography. The
designations 13 and 123 refer to the relative exposure time of the
films shown.
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served by 8 h after UV irradiation. In the presence of aphidi-
colin, the UV-induced hyperphosphorylation RPA-p34 was
absent. These data support the conclusion that UV-induced
RPA-p34 hyperphosphorylation is associated with replica-
tion of UV-damaged DNA.
ATM Dependence of RPA-p34 Hyperphosphorylation
in Aphidicolin-synchronized Cell Cultures
The next experiment was carried out to determine whether
the hyperphosphorylation of RPA-p34 observed in aphidi-
colin-treated cells after UV-irradiation was ATM dependent.
To test this hypothesis, we treated cells for 17 h with aphidi-
colin, which inhibits the elongation step of DNA replication
and blocks cell cycle progression at the G1/S border (Pe-
drali-Noy et al., 1982). Cells were then released from the
block by transferring them to fresh medium without aphidi-
colin. After an additional 2-h incubation, cells were irradi-
ated with 10 J/m2 UVC or mock-irradiated (Figure 7A). Cell
lysates were prepared at the indicated times thereafter, and
the phosphorylation state of RPA-p34 was analyzed by
Western immunoblotting. We confirmed that the cells re-
leased from the aphidicolin block had a rapid increase in
DNA synthetic activity, by measuring the incorporation of
[3H]thymidine (Figure 7B). We also confirmed that the DNA
content of cells increased by 5 h after the release of aphidi-
colin block (our unpublished results). Strong hyperphospho-
rylation of RPA p34 was observed by 4 h after UV irradia-
tion of aphidicolin-synchronized HeLa cells (Figure 7C).
Immediately after irradiation or mock irradiation, the ma-
jority of RPA-p34 in lysates prepared from LM217 or
AT5BIVA cells was in faster migrating forms of the subunit
(particularly in the doublet of bands 1 and 2; Figure 7D,
lanes 1, 2, 5, and 6). Eight hours after mock irradiation, this
pattern did not change appreciably (Figure 7D, lanes 3 and
7). At 8 h after 10 J/m2 UVC exposure, however, a slow-
mobility form (band 5) was apparent in lysates from LM217
cells (Figure 7D, lane 8) but not from A-T cells (Figure 7D,
lane 4). These data support the observation that UV-induced
hyperphosphorylation of RPA-p34 does not occur normally
in A-T cells.
DISCUSSION
We have investigated the requirements for UV radiation–
induced RPA-p34 hyperphosphorylation. Western immuno-
blotting revealed that the p34 subunit of the RPA protein
complex was hyperphosphorylated in a time- and dose-
dependent manner in normal, asynchronously growing cells
after exposure to UVC (Carty et al., 1994). This response was
both delayed and reduced in intensity in A-T cells. We have
Figure 4. Chymotryptic/tryptic phos-
phopeptide maps of in vitro–phosphory-
lated recombinant RPA-p34. (Top) Five
hundred nanograms of purified recombi-
nant RPA complex was phosphorylated by
either purified ATM or 10 U of DNA-
PKcs/Ku for 30 min. Hyperphosphorylated
RPA-p34 was separated by SDS-PAGE and
transferred to a PVDF membrane. The hy-
perphosphorylated form of RPA-p34 was
detected by phosphorimager analysis and
excised from the membrane. The hyper-
phosphorylated RPA-p34 was digested
twice with 10 mg of chymotrypsin/trypsin
and oxidized with performic acid. The di-
gested peptides were loaded onto TLC
plates and separated by electrophoresis at
pH 1.9 in the first dimension, followed by
ascending chromatography in the second
dimension. The labeled peptides were de-
tected by phosphorimager analysis. To ver-
ify identical and unique peptides, equal ra-
dioactivity from digests of DNA-PKcs/Ku and ATM-phosphorylated RPA-p34 were loaded onto the same chromatography plate and
subjected to two-dimensional separation. Numbered tryptic/chymotryptic peptides indicated on the maps with arrows refer to the peptide
sequence number (lower panel) with a letter “p” designating a phosphorylated serine or threonine on the peptide. (bottom) The amino acid
sequence of the N-terminus of RPA-p34 is shown along with the sites for cleavage by trypsin/chymotrypsin (2), sites phosphorylated by
Cdc2p34/cyclin B and consensus sites for DNA-PKcs/Ku. The asterisk denotes the cleavage site that is blocked by adjacent phosphorylated
amino acids.
Figure 5. Time course of RPA phosphorylation after irradiation of
XP12BE cells (XP complementation group A). XPA cells were either
mock-irradiated or treated with the indicated doses of UVC. At the
indicated times after treatment, cell lysates were prepared and the
RPA-p34 phosphorylation pattern was analyzed by gel electro-
phoresis, followed by immunoblotting. The arrow to the right indi-
cates the major hyperphosphorylated form of RPA-p34.
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also used recombinant ATM and antisense ATM expression
vectors to demonstrate that UV-induced RPA-p34 hyper-
phosphorylation is dependent on the expression of ATM.
Reduction of ATM levels in normal C3ABR cells, by the
expression of an antisense cDNA, decreased UV-induced
RPA-p34 hyperphosphorylation. Furthermore, expression of
a full-length recombinant ATM protein in AT1ABR cells
fully restored UV-induced RPA-p34 hyperphosphorylation
Figure 6. UVC-induced RPA-p34 hyperphosphorylation in the
presence of aphidicolin. (A) Protocol for treatment. HeLa cells were
treated with 0.3 mM nocodazole for 16 h. Mitotic cells were collected
by shaking the cells off the dish and pelleting them. To obtain cells
synchronized in G1/S phase, mitotic cells were released from no-
codazole treatment for 7.5 h in fresh medium. Cells were either
mock-irradiated or irradiated with 30 J/m2 UVC in the presence or
absence of aphidicolin (6 mM). (B) The rate of DNA synthesis after
release from nocodazole treatment was measured as 3H-thymidine
incorporation during a 30-min pulse with 10 mCi/ml 3H-thymidine
(NEN Life Science Products, Inc.). Cells were prelabeled with 0.01
mCi/ml 14C-thymidine (NEN Life Science Products, Inc.) for 24 h at
37°C, followed by 3H-thymidine pulse labeling. After labeling, cells
were washed with PBS twice and lysed with 500 ml of 0.2 M NaOH
per dish. The radioactivity of each sample was counted by dual-
label liquid scintillation, and the ratio of 3H/14C reflected the DNA
synthesis activity. (C) RPA-p34 phosphorylation in nocodazole-
synchronized HeLa cells exposed to UVC. Cells in G1/S phase were
either mock-irradiated or irradiated with 30 J/m2 UVC in the pres-
ence or absence of aphidicolin (6 mM). After preparation of whole-
cell lysates, RPA-p34 was visualized by immunoblotting with anti-
RPA-p34 antibody and ECL chemiluminescent detection.
Figure 7. UV-induced RPA-p34 phosphorylation in aphidicolin-
synchronized cells. (A) Protocol for treatment. Cells were treated
with 6 mM of aphidicolin for 16–20 h. After the medium containing
aphidicolin was removed; the cells were washed twice in serum-free
medium and further incubated in serum-containing medium with-
out aphidicolin for 2–4 h. After 2–4 h in fresh medium, the cells
were mock-irradiated or irradiated with 10 J/m2 and then incubated
in the same medium for the indicated times. (B) The rate of DNA
synthesis after release from aphidicolin treatment was measured as
3H-thymidine incorporation during a 30-min pulse with 10 mCi/ml
3H-thymidine (NEN Life Science Products, Inc.). Cells were prela-
beled with 0.01 mCi/ml 14C-thymidine (NEN Life Science Products,
Inc.) for 24 h at 37°C followed by 3H-thymidine pulse labeling. After
labeling, cells were washed with PBS twice and lysed with 500 ml of
0.2 M NaOH per dish. The radioactivity of each sample was counted
by dual-label liquid scintillation and the ratio of 3H/14C reflected
the DNA synthesis activity. (C) Time course of RPA-p34 phosphor-
ylation in HeLa cells. Whole cell lysates were prepared at various
times after mock irradiation or irradiation with 10 J/m2 UVC.
Proteins were separated on a 12% denaturing polyacrylamide gel.
After transfer of the proteins to a PVDF membrane RPA-p34 phos-
phorylation pattern was analyzed by immunoblotting using an
antibody specific for RPA-p34 (monoclonal antibody 34A). (D) RPA-
p34 phosphorylation in aphidicolin synchronized normal Lm217
and A-T cells exposed to UVC. Cells were irradiated with 10 J/m2
UVC or mock-irradiated 2 h after release from the aphidicolin block.
Cell lysates were prepared 0 or 8 h after irradiation. The p34 subunit
of RPA was analyzed by immunoblotting.
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in these cells. We conclude that ATM expression is required
for UV-induced RPA-p34 hyperphosphorylation.
Our conclusions appear to differ from those of Liu and
Weaver (1993), who observed that A-T cells were deficient in
hyperphosphorylation of RPA-p34 in response to IR but not
UV radiation. With IR, hyperphosphorylation of RPA-p34
was reduced and delayed in A-T cells compared with nor-
mal cells. UV-induced hyperphosphorylation of RPA-p34
was examined only up to 3 h after irradiation (Liu and
Weaver, 1993). At these early times, little difference was
observed between A-T cells and normal cells; after 500 J/m2
UV, strong hyperphosphorylation of RPA-p34 was observed
in both A-T and normal cells; after 50 J/m2 UV, hyperphos-
phorylation of RPA-p34 was observed in some A-T and
normal cells but not others; and after 10 J/m2 UV, little
hyperphosphorylation was observed in either cell type. Be-
cause the ATM-dependent phosphorylation pathway we are
investigating was induced at later times (4–8 h after UV
irradiation) and at lower UV fluences (10–30 J/m2), our
results are not, in fact, in direct conflict with those of Liu and
Weaver (1993).
Our observation that purified ATM has the capacity to
phosphorylate RPA-p34 in vitro suggests that the ATM ki-
nase may participate directly in UV-induced RPA-p34 hy-
perphosphorylation in vivo. However, it is possible that the
requirement of ATM for UV-induced RPA-p34 hyperphos-
phorylation is indirect and other kinases may be involved.
We showed previously that DNA-PK phosphorylates in
vitro many of the same sites within the N-terminus of RPA-
p34 that are phosphorylated in vivo after UV-irradiation
(Ser-11, Ser-12, or Ser-13 on peptide 4; Thr-21and Ser-23 on
peptide 6; Ser-29 and Ser-33 on peptide 7; also probably Ser
4 on peptide 2, and Ser 8 on peptide 3; Zernik-Kobak et al.,
1997). However, several lines of evidence suggest that
DNA-PK is not the only kinase required for RPA-p34 phos-
phorylation after DNA damage. For example, human DNA-
PKcs–deficient glioblastoma cells M059J hyperphosphory-
lated RPA-p34 after IR (Fried et al., 1996). This is in
agreement with our observation that RPA-p34 hyperphos-
phorylation occurred in UV-irradiated M059J cells, albeit to
a lesser extent. Our observations agree with other reports
that M059J cells have extremely low levels of ATM protein.
The lower levels of ATM, rather than the lack of DNA-PK,
may account for the decreased levels of hyperphosphory-
lated RPA-p34 observed in these cells after genotoxic insult
(Chan et al., 1998; Gately et al., 1998). A role for ATM in
RPA-p34 phosphorylation is also supported by the demon-
stration that ATM immunoprecipitates from MO59J cells
retain in vitro kinase activity toward RPA-p34 (Gately et al.,
1998). Here we show that the sites of phosphorylation of
RPA-p34 by ATM in vitro are similar to those of DNA-PK
and therefore similar to those that occur in vivo. It is possible
that both DNA-PK and ATM may participate in some way in
UV-induced RPA-p34 hyperphosphorylation.
Another candidate for in vivo phosphorylation of RPA-
p34 is ATR. Expression of kinase-inactive ATR protein
(ATRkd) in human fibroblasts increased sensitivity to UV
and IR and led to loss of cell cycle checkpoint control
(Wright et al., 1998). Although ATR kinase does not phos-
phorylate RPA-p34 in vitro (Hall-Jackson et al., 1999), the
functional overlap between ATM and ATR suggests that
RPA-p34 may be an in vivo substrate for ATR. Although
ATM has been implicated in IR-induced RPA-p34 hyper-
phosphorylation and ATM-immune precipitates of IR-
treated cells phosphorylated RPA-p34 (Gately et al., 1998), a
direct role for ATM kinase in IR-induced hyperphosphory-
lation has also not yet been demonstrated.
The signal for IR-induced, ATM-dependent RPA-p34 hy-
perphosphorylation is thought to be IR-induced DNA
strand breaks (Liu and Weaver, 1993), although no direct
evidence for this hypothesis has been provided. UV radia-
tion induces primarily cyclobutane pyrimidine dimers and
6-4 photoproducts. Because UV-induced RPA-p34 hyper-
phosphorylation only occurs several hours after UV irradi-
ation, UV photoproducts are not likely to be the primary
inducing signal. There are several different pathways by
which cells process UV-induced DNA damage (Figure 8)
that might generate the signal for ATM-dependent RPA-p34
hyperphosphorylation. In normal cells, most UV-induced
Figure 8. Model for cellular processing of UV-induced DNA dam-
age. UV radiation induces mainly pyrimidine cyclobutane dimers
and 6-4 photoproducts. The majority of these are repaired by nu-
cleotide excision repair (NER), which involves recognition of the site
of damage by XPA with the assistance of RPA and the recruitment
of additional repair proteins that incise the DNA on either side of
the damage, release a single-stranded oligonucleotide containing
the damage and fill in the resulting gap. If cells are in S phase and
DNA replication occurs before all the damage is repaired, the DNA
replication fork may encounter sites of damage. One of several
specialized DNA polymerases may facilitate replication past the
damage. If replication becomes stalled at sites of DNA damage,
mechanisms of postreplication repair (PRR) are activated. This ac-
tivation appears to involve the ATM kinase, which phosphorylates
RPA and NBS1. The MRE11/RAD50/NBS1 complex may partici-
pate in processing the incompletely replicated DNA, facilitating
recombinational repair.
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DNA damage is repaired by NER, which generates DNA
single-strand breaks as transient intermediates (Kaufmann
and Wilson, 1990). However, nucleotide excision repair does
not appear to be required for induction of RPA-p34 hyper-
phosphorylation by UV radiation, because we showed that
hyperphosphorylation was induced normally in XPA cells.
Our observations and others (Rodrigo et al., 2000) that
UV-induced RPA-p34 hyperphosphorylation was blocked
when DNA replication was inhibited by aphidicolin argue
that the inducing signal for ATM-dependent RPA-p34 hy-
perphosphorylation is generated during replication of UV-
damaged DNA templates. Models for replication of UV
damaged DNA templates and postreplication repair were
first proposed in the early 1970s to explain the induction of
chromosomal aberrations by UV and chemical carcinogens
(Bender et al., 1973, 1974); these models have been refined
more recently to include new information on mechanisms of
postreplication repair (Seigneur et al., 1998). When DNA
replication occurs while UV-photoproducts remain in the
DNA, some of these lesions block the progression of the
DNA replication fork (Park and Cleaver, 1979). This block-
age is sometimes overcome by the action of DNA poly-
merases (e.g., polymerases h and z and the product of
hREV1) that have the capacity to bypass UV photoproducts
(Gibbs et al., 1998; Lin et al., 1999; Masutani et al., 1999).
However, if the blockage persists, aberrant DNA replication
intermediates are produced that contain long regions of
single-stranded DNA; double-strand DNA breaks also accu-
mulate (Wang and Smith, 1986; Kaufmann, 1989; Michel et
al., 1997). Although the exact nature of the inducing signal
remains to be elucidated, it is interesting to note that ATM-
dependent RPA-p34 phosphorylation in vitro is activated by
closed circular single-stranded DNA. If the double-strand
breaks that accumulate after UV radiation are the inducing
signal, this would suggest similarities between the signals
for IR- and UV-induced ATM activation. Recently, it was
shown that DNA replication was also required for induction
of RPA-p34 hyperphosphorylation by adozelesin, a DNA-
alkylating agent, but not by IR (Liu et al., 2000). Like UV,
adozelesin would be expected to cause DNA replication–
blocking lesions.
The aberrant replication intermediates that accumulate
after UV radiation are thought to be resolved through a
recombinational mechanism between sister chromatids
(Bender et al., 1973, 1974; Kaufmann, 1989; Haber, 2000;
Lowndes and Murguia, 2000). However, the enzymology of
this process is not yet understood. Recently, Limoli et al.
(2000) demonstrated colocalization of PCNA (involved in
DNA replication) and the MRE11 complex (Mre11/Rad50/
Nbs1, involved in recombinational repair) in foci 4–8 h after
UV radiation of XPV human fibroblasts (deficient in DNA
polymerase h). This result implicates the MRE11 complex in
recognition and/or resolution of DNA replication interme-
diates after UV radiation. Indeed, it has been suggested that
this complex performs a similar role during replication of
undamaged templates (Petrini, 2000). Because NBS1 appears
to be a substrate for the ATM kinase (Gatei et al., 2000; Lim
et al., 2000), it is possible that MRE11 focus formation in
response to UV damage also involves ATM (Petrini, 2000).
ATM-dependent RPA-p34 hyperphosphorylation may occur
in concert with phosphorylation of other members of this
complex.
ATM-dependent phosphorylation events are involved in
IR-induced checkpoint control. The radioresistant DNA syn-
thesis observed in A-T cells is attributed to the loss of the
S-phase checkpoint. Interestingly, mutation of the ATM ki-
nase phosphorylation site on NBS1 also leads to loss of the
IR-induced, S-phase checkpoint (Lim et al., 2000). This ob-
servation suggests that the MRE11 complex may play a role
in IR-induced ATM-dependent cell signaling. Whether
phosphorylation of NBS1 or RPA plays a role in UV-induced
checkpoint control has not yet been determined.
Presently, there is no definitive evidence for a functional
role of RPA hyperphosphorylation. However, a number of
lines of evidence suggest that phosphorylation may alter the
activity of RPA for DNA replication, NER, and double-
strand break repair (reviewed in Iftode et al., 1999). The
strong binding affinity of the three-subunit RPA complex for
ssDNA is predominantly attributed to the RPA-p70 subunit;
the 34-kDa subunit is thought to play a regulatory role
(Wold, 1997; Bochkareva et al., 1998; Iftode et al., 1999). RPA
also binds with high affinity to certain double-stranded
DNA regulatory sequences (Singh and Samson, 1995; Tang
et al., 1996) and to double-stranded DNA carrying UV pho-
toproducts or cis-platin DNA cross links (Clugston et al.,
1992; Burns et al., 1996; Patrick and Turchi, 1998). RPA has a
double-stranded DNA unwinding activity, which is altered
by phosphorylation (Georgaki et al., 1992; Georgaki and
Hubscher, 1993). We have shown that the DNA replication
capacity was reduced in extracts from UV-irradiated human
cells (containing hyperphosphorylated RPA), but replication
capacity could be restored by the addition of purified RPA
(Carty et al., 1994). A similar observation was recently made
with extracts from adozelesin-treated cells (Liu et al., 2000).
Park et al. (1999) reported DNA synthesis inhibition in RPA-
enriched replication extracts from UV-treated MO59K
(DNA-PKcs1) cells but not in cell extracts from MO59J
(DNA-PKcs2) cells, implying modulation of RPA by DNA-
PK. However, interpretation of these data is complicated by
the fact that the DNA-PKcs–deficient glioblastoma cells
(MO59J) also have reduced amounts of ATM compared with
the control line (MO59K). Rodrigo et al. (2000) reported a
temporal parallel between RPA-p34 hyperphosphorylation
and DNA synthesis inhibition after UVC irradiation, and
Shao et al. (1999) reported a similar relationship after camp-
tothecin treatment. In addition, Henricksen et al. (1996) dem-
onstrated that phosphorylation of RPA-p34 modulates DNA
replication. Also, RPA phosphorylation reduces the ability
of RPA to interact with DNA polymerase a-primase (Iftode
et al., 1999) and p53 (Abramova et al., 1997). It is not clear
how these in vitro observations relate to RPA function in
vivo and in particular to DNA repair functions or the S-
phase checkpoint.
What is the biological significance of a role for ATM in
cellular responses to UV-induced DNA damage? A-T pa-
tients are acutely sensitive to ionizing radiation, but no
enhanced sensitivity to UV radiation has been documented
(Paterson and Smith, 1979; Sedgwick and Boder, 1991;
Woods and Taylor, 1992; Taylor et al., 1994). Likewise A-T
cells exhibit enhanced sensitivity to killing by IR but not UV.
However, there are abnormalities in the response of A-T
cells to UV radiation. Both the accumulation of DNA strand
breaks and the subsequent generation of chromosome aber-
rations are elevated in UV-irradiated A-T cells (Sasaki, 1980;
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Ejima and Sasaki, 1986; Kaufmann, 1989; Kaufmann and
Wilson, 1994). Kaufmann and Wilson demonstrated that the
greatest numbers of chromosomal aberrations occurred
when normal cells were UV irradiated at the G1/S border
and that A-T fibroblasts were hypersensitive to the induc-
tion of chromosomal aberrations by UV (Kaufmann and
Wilson, 1994). The fact that UV induces mainly chromatid-
type chromosomal aberrations suggests that they arise after
DNA replication has occurred (Kaufmann, 1989). This ab-
normality in response to UV in A-T cells likely reflects an
abnormality in response to DNA replication-blocking le-
sions in general, which would include those caused by car-
cinogens that form bulky adducts (e.g., benzo[a]pyrene) and
alkylated bases (e.g., methyl methane sulfonate). Indeed a
very similar response was observed in adozelesin-treated
cells (Liu et al., 2000). Perhaps this defect in response to a
broader range of DNA-damaging agents accounts for the
appearance of a broad spectrum of cancers in adult A-T
patients (Meyn, 1999). Recently ATM has been linked to
other chromosome instability syndromes through its appar-
ent interaction with the MRE11/RAD50/NBS1 complex.
The MRE11 gene has been found to be mutated in two
patients with an A-T-like syndrome (Stewart et al., 1999),
and the NBS1 gene is mutated in Nijmegen breakage syn-
drome (Gatei et al., 2000; Lim et al., 2000; Petrini, 2000; Wu et
al., 2000; Zhao et al., 2000). Perhaps all of these diseases share
a postreplication repair defect.
In summary, we have demonstrated that the RPA-p34
hyperphosphorylation that occurs in response to UV radia-
tion is dependent on DNA replication and expression of the
ATM kinase. We postulate that this pathway is induced in
response to abnormal DNA replication intermediates that
accumulate as a result of DNA replication fork blockage by
UV photoproducts. Further, we suggest ATM plays a role in
signaling to components of the postreplication repair appa-
ratus, including RPA, to trigger recombinational repair and
prevent the formation of chromosomal aberrations resulting
from unresolved replication intermediates.
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